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1176Objective: The effect of mechanical preconditioning on skeletal myoblasts in engineered tissue constructs
was investigated to resolve issues associated with conduction block between skeletal myoblast cells and
cardiomyocytes.
Methods:Murine skeletal myoblasts were used to generate engineered tissue constructs with or without appli-
cation of mechanical strain. After in vitro myotube formation, engineered tissue constructs were co-cultured for
6 days with viable embryonic heart slices. With the use of sharp electrodes, electrical coupling between engi-
neered tissue constructs and embryonic heart slices was assessed in the presence or absence of pharmacologic
agents.
Results: The isolation and expansion procedure for skeletal myoblasts resulted in high yields of homogeneously
desmin-positive (97.1%  0.1%) cells. Mechanical strain was exerted on myotubes within engineered tissue
constructs during gelation of the matrix, generating preconditioned engineered tissue constructs. Electrical cou-
pling between preconditioned engineered tissue constructs and embryonic heart slices was observed; however,
no coupling was apparent when engineered tissue constructs were not subjected to mechanical strain. Coupling
of cells from engineered tissue constructs to cells in embryonic heart slices showed slower conduction velocities
than myocardial cells with the embryonic heart slices (preconditioned engineered tissue constructs vs embryonic
heart slices: 0.04  0.02 ms vs 0.10  0.05 ms, P ¼ .011), lower maximum stimulation frequencies (precondi-
tioned engineered tissue constructs vs embryonic heart slices: 4.82  1.42 Hz vs 10.58  1.56 Hz; P ¼ .0009),
and higher sensitivities to the gap junction inhibitor (preconditioned engineered tissue constructs vs embryonic
heart slices: 0.22  0.07 mmol/L vs 0.93  0.15 mmol/L; P ¼ .0004).
Conclusions:We have generated skeletal myoblast–based transplantable grafts that electrically couple to myo-
cardium. (J Thorac Cardiovasc Surg 2012;144:1176-84)Supplemental material is available online.Skeletal myoblast cells (SMBs) have been investigated for
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The Journal of Thoracic and Cardiovascular Sur1990s. Despite limited information about safety and effi-
cacy, Hagege and colleagues1 applied SMBs in a clinical
trial. As shown in the Myoblast Autologous Grafting in Is-
chemic Cardiomyopathy trial, the inability of SMBs to inte-
grate functionally and electrically to the host myocardium
resulted in adverse ventricular arrhythmias.2 At the same
time, it was demonstrated that unmodified transplanted
SMBs neither integrate into the host myocardium nor trans-
differentiate into cardiomyocytes.3
On the other hand, it has been shown that SMBs, which
have been preconditioned before transplantation, were
able to integrate into the host myocardium.4-11 The
preconditioning regimens included virally mediated
expression of connexin43 (Cx43), in vitro co-culturing of
SMBs with cardiomyocytes, and chemical induction of
Cx43 expression. Because autologous cardiomyocytes are
difficult to obtain and there are safety issues associated
with transgenic approaches, these methods may not be clin-
ically relevant.
Other cell types that have been applied for cardiac cell
therapy approaches include mesenchymal stem cells, endo-
thelial progenitor cells, and cardiac cells derived from plu-
ripotent stem cells. Although all of these cells have beengery c November 2012
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AP ¼ action potential
Cx43 ¼ connexin43
DMEM ¼ Dulbecco’s Modified Eagle Medium
EGFP ¼ enhanced green fluorescent protein
EHS ¼ embryonic heart slice
ETC ¼ engineered tissue construct
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K-ETC ¼ killed engineered tissue construct
NP-
ETC
¼ nonpreconditioned engineered tissue
construct
P-ETC ¼ preconditioned engineered tissue
construct
SMB ¼ skeletal myoblast cell
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mechanisms remain unknown. Furthermore, we have
shown that the quality of autologous progenitor cells (ie,
mesenchymal stem cells) is dependent on patient-specific
factors.13 Because of ethical and safety reasons, so-called
embryonic stem cells and induced pluripotent stem cells, re-
spectively, are not considered for clinical application at this
time.
Our group14 previously demonstrated a method to pre-
condition rat SMBs in a manner that could be clinically ap-
plicable. By seeding the cells into a 3-dimensional hydrogel
construct and subjecting them to tensile strain, the expres-
sion levels of proteins essential for functional and electrical
coupling were significantly increased. After transplanta-
tion, the skeletal cells were able to establish an accessory
conduction pathway as a potential treatment for atrioven-
tricular conduction block.
We sought to address known electrophysiologic issues of
SMB transplantation for cardiac therapy2 by investigating
the electrical coupling properties of SMBs, embedded in
mechanically preconditioned engineered tissue constructs
(ETCs), to myocardium in an ex vivo transplantation model.MATERIALS AND METHODS
Isolation and Cell Culture of Skeletal Myoblast Cells
Animals received humane care in compliance with the Principles of
Laboratory Animal Care, formulated by the National Society of Medical
Research, and the Guide for the Care and Use of Laboratory Animals, pre-
pared by the National Academy of Sciences and published by the National
Institutes of Health (Publication No. 86-23, revised 1996). The Institutional
Animal Care and Use Committee approved all experiments. All experi-
ments were approved by the local institutional and governmental
authorities.
SMBs were isolated from the limb muscle tissue of neonatal C57BL/6
mice as described previously.15 The tissue sample processing involved in-
cubation in 0.2% type IV collagenase (Invitrogen, Karlsruhe, Germany),
2.4 IU/mL dispase (Invitrogen) and 3 mmol/L CaCl2 (Sigma-Aldrich, Mu-
nich, Germany) in phosphate-buffered saline (Invitrogen). Isolation me-
dium containing Ham’s F10 medium (Invitrogen), 20% fetal bovineThe Journal of Thoracic and Carserum (FBS, Invitrogen), and 2.5 ng/mL basic fibroblast growth factor (Pe-
proTech, Hamburg, Germany) was applied for culturing the cells at a den-
sity of 1 3 105 cells/cm2 on collagen-coated plates (5 mg/cm2 type I
collagen, Invitrogen). Preplating procedures (ie, further culture of suspen-
sion cells, while adherent cells were discarded) were applied after 1, 2, 18,
and 48 hours of incubation. After a further incubation for 48 hours, the ad-
herent cells were expanded in growth medium: 40% Ham’s F10 medium,
40% Dulbecco’s Modified Eagle Medium (DMEM, Invitrogen), and 20%
FBS, 2.5 ng/mL basic fibroblast growth factor. Ten days after isolation at
80% confluence, differentiation of SMBs to myotubes was triggered by
a change in culture conditions to differentiation medium: DMEM, 2%
horse serum (PAA, Coelbe, Germany), which was changed daily for 14
days. All media were supplemented with penicillin/streptomycin (1:100)
and fungizone (1:1000, both Invitrogen).
Fabrication of Engineered Tissue Constructs
ETC fabrication was based on a slightly modified method as previously
published.15 The matrix scaffold for the ETC was prepared by mixing ice-
cold isolation medium, type I collagen (5 mg/mL, Invitrogen), and 0.1
mol/L NaOH and Geltrex (Invitrogen) at a ratio of 3:3:1:1. SMBs were la-
beled with Vybrant DiI (Invitrogen) according to the manufacturer’s in-
structions before using for ETCs. A defined number (5 3 106) of SMBs
were resuspended in 200 mL isolation medium and mixed with 500 mL
of the premixed matrix.
To fabricate preconditioned ETC (P-ETCs), the mixture was cast into
molds composed of silicone tubing cut in half lengthwise with monofila-
ment polyester mesh (0.331 opening; McMaster-Carr, Elmhurst, Ill) at-
tached to each end with silicone adhesive (Rhodia, Cranbury, NJ).
Constructs were warmed at 37C to induce gelling and covered with myo-
blast culture media.
For the fabrication of nonpreconditioned ETCs (NP-ETCs), the suspen-
sion was poured directly on a cell culture dish (BD Biosciences, Heidel-
berg, Germany). The tissue constructs were first incubated at 37C in
isolation medium for 3 days followed by incubation in differentiation me-
dium for 11 days. The complete timeline of the ETC fabrication protocol is
as follows: skeletal muscle tissue preparation (day 0), preplating (days 0-3),
cell culture expansion (days 3-10), ETC generation (day 10), ETC cell cul-
ture (days 10-13), ETC differentiation (days 13-24), and co-culture with
embryonic heart slices (EHSs) (days 24-30).
Preparation of Embryonic Ventricular Heart Slices
Vital EHSs from day 18 C57BL/6 mice, expressing enhanced green
fluorescent protein (EGFP) under control of the cardiac specific a-actin
promoter, were prepared as described previously.16,17 Briefly, the
explanted hearts were prepared and embedded in 4% low-melt agarose
(Roth, Karlsruhe, Germany). These agarose blocks were subsequently sec-
tioned into 300-mm–thick transversal sections using a VT1000s microtome
(Leica, Wetzlar, Germany) and stored in preoxygenized ice-cold Tyrode’s
solution (composition in mmol/L: NaCl 136, KCl 5.4, NaH2PO4 0.33,
MgCl2 1, D-glucose 10, 2,3-butanedione monoxime 30, and N-2-
hydroxyethylpiperazine-N’-2-ethanesulfonic acid 5; pH 7.4). After sec-
tioning, CaCl2 (Sigma-Aldrich) was added to a final concentration of 0.9
mmol/L, and the tissue slices were incubated for 30 minutes at 4C. The
EHSs were washed twice in phosphate-buffered saline and transferred to
a 10-cm dish (BD Biosciences) containing ice-cold Iscove’s modified Dul-
becco’s medium (Invitrogen) supplemented with 20% FBS (Invitrogen).
EHSs were incubated for 1 hour in a standard cell-culture incubator and
then used for co-culture with ETCs.
Engineered Tissue Construct Preparation and
Co-Culture With Embryonic Heart Slices
On day 11 of differentiation cell culture, the center regions (2-mm long)
of P-ETCs were prepared using a sterile scalpel. The center parts ofdiovascular Surgery c Volume 144, Number 5 1177
FIGURE 1. Isolation and characterization of SMBs. Bright field micrograph (A) and (B) immunocytochemical staining of SMBs after 7 days of cell cul-
ture: desmin (green), connexin43 (Cx43, red), and 40,6-diamidino-2-phenylindole-dihydrochloride (blue). C, Flow cytometric quantification of desmin ex-
pression in SMBs after preplating (day 3) and cell culture expansion (day 10). D, Quantification of total cell yield per 100 mg muscle tissue and fraction of
desmin-positive cells after preplating (day 3) and cell culture expansion (day 10, ***P<.0001; n ¼ 5). Bright field micrograph (E) and (F) immunocyto-
chemical staining of SMBs differentiated to myotubes: a-actinin (ACTN, green), Cx43 (red), and 40,6-diamidino-2-phenylindole-dihydrochloride (blue)
after 14 days of differentiation. Scale bars ¼ 50 mm.
Evolving Technology/Basic Science Neef et al
E
T
/B
SNP-ETCs were cut into similarly sized and shaped pieces. Control ETCs
containing dead cells (killed [K]-ETCs) were prepared by immersing
P-ETCs in distilled water for 24 hours.
EHSs and ETCs were transferred to a custom-made well chamber with
a funnel-shaped cavity (funnel dish) to facilitate physical contact between
EHSs and ETCs. After 6 days of incubation in differentiation medium, co-
cultures were used for immunohistochemistry and electrophysiologic
assessment.
Histology
Tissue samples were snap-frozen in TissueTek (Sakura Finetek, Stau-
fen, Germany) and cut into 8-mm sections with a CM1950 cryotome
(Leica).
For histochemistry, the sections were fixed with acetone and stained
with Masson’s trichrome (both Sigma-Aldrich) following the manufac-
turer’s instructions.
For immunohistochemistry, the sections were fixed (4% paraformalde-
hyde) and permeabilized (0.25%Triton X-100). Unconjugated primary an-
tibodies used for immunocytochemistry included anti-desmin (GeneTex,
Irvine, Calif), anti-connexin45 (Millipore, Schwalbach, Germany), anti-
Cx43, anti–N-cadherin (both Abcam, Cambridge, UK), anti–sarcomeric-
a-actinin (Sigma-Aldrich), anti-dystrophin, (Santa Cruz, Heidelberg,
Germany), and anti-EGFP (Invitrogen). Primary antibodies were detected
with species-specific AlexaFluor conjugated secondary antibodies. Nuclei
were stained with 40,6-diamidino-2-phenylindole-dihydrochloride (both
Invitrogen). Fluorescence microscopy was performed with an Eclipse
Ti-U microscope using the NIS Elements BR 3.10 software package
(Nikon, D€usseldorf, Germany).
Electrophysiologic Analysis
The funnel dish with the co-culture sample in 3 mL serum-free DMEM,
oxygenated with O2/CO2 (95%/5%), was placed on a custom-made1178 The Journal of Thoracic and Cardiovascular Surheating plate (37C). Electrophysiologic measurements were performed
with sharp electrodes (20-40 MU when filled with 3 mol/L KCl) made of
filament borosilicate glass capillaries (WPI, Sarasota, Fla). Signals were
amplified with a SEC-10LX amplifier (NPI Electronic, Tamm, Germany)
and acquired with Pulse software (HEKA, Lambrecht, Germany). A de-
fined stimulation frequency (2-15 Hz) was applied using a square pulse
stimulator (SD9; Grass Technologies, West Warwick, RI). Data were ana-
lyzed with theMini Analysis program (Synaptosoft, Fort Lee, NJ). Pharma-
cologic inactivation of gap junctions was performed by titrating defined
volumes (2-100 mL) of 1-heptanol (Sigma-Aldrich) to the medium.
Statistical Analysis
Numeric data are expressed as mean  1 standard deviation. Statistical
analyses were performed using the Statistical Package for the Social Sci-
ences (release 20; IBM, Somers, NY). Data were tested by 1-way analysis
of variance followed by a Bonferroni post hoc test for multiple
comparisons.RESULTS
Isolation and Culture of Skeletal Myoblast Cells
The SMB isolation process yielded 3.80  1.77 3 106
cells per 100 mg (n¼ 5) of skeletal muscle tissue from neo-
natal mice. After 3 preplating steps and a subsequent incu-
bation for 48 hours, the total cell number was reduced to
approximately 50%. The majority of the remaining adher-
ent cells showed the typical spindle-shaped morphology of
SMBs (Figure 1, A), and immunocytochemical analysis re-
vealed a majority of these cells to be positive for desmin
(Figure 1, B). This was confirmed quantitatively by flowgery c November 2012
FIGURE 2. Characterization of ETCs. SMBs and myotubes from nonpreconditioned engineered tissue construct (NP-ETC; A-D) and preconditioned en-
gineered tissue construct (P-ETC; E-H) conditions. Macroscopic images of NP-ETC (A) and P-ETC (E). Immunohistochemical staining confirms increased
gap junction (arrows, connexin43 [Cx43] and connexin45 [Cx45]) and adhesion protein (N-cadherin [N-Cad]) expression for P-ETC (F-H) compared with
NP-ETC (B-D). The regression pattern of myotube-specific (dystrophin) and muscle-specific structural markers (a-actinin [ACTN]) was similar for both
conditions. Scale bars ¼ 50 mm.
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desmin-positive cells. A further 10 days of cell culture ex-
pansion yielded 86.71  10.66 3 106 cells per 100 mg of
tissue with even further increased purity of desmin-
positive cells (97.1%  0.1%, n ¼ 5; Figure 1, C and D).
When changing culture conditions to differentiation me-
dium, SMBs changed morphology and fused to multinucle-
ated, spontaneously contracting myotubes, showing
expression of sarcomeric a-actinin but not retaining expres-
sion of gap junction protein Cx43 (Figure 1, E and F).
Construct Morphology and Co-Culture
SMBs from cell culture expansion were used for the fab-
rication of ETCs. The application of 53 106 cells per ETC
resulted in a homogeneous and longitudinal alignment of
myotubes in P-ETC, whereas NP-ETCs showed no defined
orientation of cells (Figure 2, A, B, E, and F). Immunohis-
tochemical analysis revealed ubiquitous expression of dys-
trophin and sarcomeric a-actinin for cells within the ETCs.
Expression of gap junction proteins Cx43 and connexin45,
as well as adherens junction protein N-cadherin, was detect-
able only in P-ETCs and not in NP-ETCs (Figure 2, B, D, F,
and H).
Co-Culture and Electrophysiologic Analyses
For co-cultures, the center sections of ETCs were pre-
pared to obtain the regions of the ETCs with the highest
and most reproducible longitudinal alignment of embedded
SMBs15 and carefully positioned in funnel dishes to guaran-
tee direct contact with the EHSs. For 8 of 10 co-culture
experiments, P-ETCs and EHSs remained physically at-
tached for 6 days during co-culture (NP-ETCs: 6/10;
K-ETCs: 4/10; Figure E1, A-G).The Journal of Thoracic and CarElectrophysiologic measurements were performed to in-
vestigate electrical coupling between cells in the ETCs and
EHSs. Sharp glass electrodes were used to target individual
cells in EGFP-positive EHSs for recording of intracellular
action potentials (APs) after stimulation in ETCs or EHSs
(Figure 3, A and B).
When the stimulation electrode was placed in the ETCs
(S1-R), only the P-ETC group demonstrated APs in unison
with EHS cells (Figure E1, H), as opposed to the NP-ETC
and K-ETC groups, in which only APs from spontaneous
contractions of the EHSs were observed. In all 3 conditions,
stimulation within the EHSs (S2-R) resulted in APs spread-
ing between cells in the EHS, which reflects the viability
and excitability of the EHS (Figure 3, C-E).
APs from stimulation at 4 Hz from P-ETCs showed lon-
ger delays to stimulation trigger than APs from stimulation
from EHSs (Figure 4, A) and resulted in a significantly
lower conduction velocity when normalized to distance be-
tween location of stimulation and recording (0.04  0.02
ms vs 0.10  0.05 ms, P ¼ .011; n ¼ 5; Figure 4, B).
To further assess the quality of electrical coupling be-
tween ETCs and EHSs, increased stimulation frequencies
were applied. There were significantly higher maximal
stimulation frequencies for stable electrical coupling
when stimulation within the EHSs was compared with stim-
ulation from the ETCs (Figure 4, C-F; 4.82  1.42 Hz vs
10.58 1.56 Hz; P¼ .0009; n¼ 5). Higher stimulation fre-
quencies led to irregular ‘‘skips’’ in the resulting APs
(Figure 4, D).
To verify that the stimulation was propagated through
electrical coupling by gap-junctions between cells, and
not a conduction artifact caused by a field stimulation
effect, the gap-junction inhibitor 1-heptanol was addeddiovascular Surgery c Volume 144, Number 5 1179
FIGURE 3. Electrophysiologic measurements of EHSs co-cultured with ETCs. A, Positions of electrodes for electrophysiologic measurements: stimula-
tion in the ETC (S1), stimulation in the EHS (S2), and recording in the EHS (R). B, eGFP-positive embryonic ventricle slice (EHS) in co-culture with ETC.
C-E, Representative APs measured at R from stimulation at S1 (ETC) and S2 (EHS) for killed engineered tissue construct (K-ETC; C), nonpreconditioned
tissue construct (NP-ETC; D), and preconditioned engineered tissue construct (P-ETC; E). Traces on the left show AP at R from stimulation at S1 (ETC to
EHS), and traces on the right show AP at R from stimulation at S2 (EHS to EHS). Scale bars ¼ 1 mm.
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evoke APs.
Although 1-heptanol eventually blocked AP generation
in the EHSs independently of whether the stimulation orig-
inated in the ETCs or within EHSs, the concentration of in-
hibitor was significantly lower for ETC-to-EHS conduction
block compared with EHC-to-EHS conduction block
(Figure 4, G-J; 0.22  0.07 mmol/L vs 0.93  0.15
mmol/L; P ¼ .0004; n ¼ 3).
The observed blocking effects were completely reversible
under decreasing 1-heptanol concentrations (Figure E1, I).Histologic Analyses of Co-Cultures
Histochemistry (Masson’s trichrome; Figure 5, C) of the
border zone revealed close physical contact of ETCs and
EHCs, but a markedly lower cell density in the ETCs com-
pared with the EHSs. Immunohistochemistry demon-
strated desmin expression across the border zone, with
less expression of this protein in the ETCs compared
with the EHSs (Figure 5, D). Cx43 expression was high
in the EHSs and in the immediate border zone to the1180 The Journal of Thoracic and Cardiovascular SurETCs with only minimal expression within the ETCs
(Figure 5, E).DISCUSSION
In the present study, we investigated the physical and
electrophysiologic integration of SMB-based ETCs in an
in vitro transplantation model. Our major findings can be
summarized as follows:
First, we have shown highly efficient isolation of expand-
able SMB populations from neonatal murine muscle tissue.
Cells from these preparations nearly ubiquitously expressed
the myogenic marker desmin, emphasizing the absence of
contaminating fibroblasts and homogeneity of enriched
cells with a functional muscle cell phenotype. Subsequent
change of cell culture conditions led to differentiation of
single cell SMBs to syncytical, spontaneously contracting
myotubes, underlining the efficient generation of cellular
structures with the ability to generate contractile force.
Second, ETCs produced with SMBs and matrix compo-
nents were subjected to unidirectional strain during
differentiation of the cells into contractile myotubes.gery c November 2012
FIGURE 4. Characterization of electrophysiologic coupling between preconditioned engineered tissue constructs (P-ETC) and embryonic heart slice
(EHS). A and B, Conduction velocity: overlay of exemplary EHS APs (A) evoked by unipolar stimulation in the ETC (S1) and EHS (S2). Significant dif-
ferences in conduction velocity measurements (B) between P-ETC to EHS and EHS to EHS. C-F, Maximum stimulation frequency: P-ETC stimulation and
EHSmeasurement showAPs at 5.5 Hz stimulation (C), but resulting in conduction blocks at 7 Hz (D), whereas EHS stimulation follows EHS recording until
12 Hz without conduction blocks (E), resulting in different maximum stimulation frequency between P-ETC to EHS and EHS to EHS measurements (F).
G-J, 1-Heptanol sensitivity: AP at EHS from 5.5 Hz stimulation at P-ETC before 1-heptanol treatment (G) and after addition of 0.2 mmol/L 1-heptanol (H).
Stimulation at EHS still results in AP at EHS at 0.2 mmol/L 1-heptanol (I) and 1-heptanol blocking concentration (J) between P-ETC to EHS and EHS to
EHS measurements. *P<.05. ***P<.001, n ¼ 5.
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sion of gap junction and adherens junction proteins, which
are necessary for the functional integration of (transplanted)
cells in the heart. In ETCs that were not mechanically stim-
ulated (NP-ETCs), these proteins were expressed at low
levels and the cells in the constructs remained unorganized.
Third, co-culture of P-ETCs and vital EHSs, which
served as an in vitro transplantation model, showed physical
engraftment of the engineered tissue with the native tissue
and electrophysiologic integration of skeletal muscle–de-
rived cells in ETCs to cardiomyocytes in vital EHSs. ByThe Journal of Thoracic and Carusing sharp electrode measurements, we quantitatively de-
termined the efficiency of the coupling between ETCs and
EHSs and compared values for conduction velocity, maxi-
mum stimulation frequency, and sensitivity to specific
pharmacologic gap junction inhibitors to native electro-
physiologic coupling within the EHS, serving as an internal
positive control. Our results clearly showed electrophysio-
logic coupling of cells within the ETC to cells within the
EHS, but for all 3 parameters examined, this occurred to
a lesser extent than the coupling of cells within the native
heart tissue.diovascular Surgery c Volume 144, Number 5 1181
FIGURE 5. Histologic analysis of co-cultured engineered heat tissue slices and engineered heart tissue at day 6. A, Macroscopic fluorescence picture of
EHS (green: enhanced green fluorescent protein [EGFP]) and P-ETC (red: Vybrant DiI [Invitrogen, Karlsruhe, Germany]). B, Fluorescence micrograph of
the P-ETC/EHS border zone. C, Masson’s trichrome staining of the P-ETC/EHS border zone (blue: collagen, red: cytoplasm). Immunohistochemical stain-
ing for desmin (green) (D) and EGFP (green) and Cx43 (red) (E) in P-ETC/EHS border zone. Cx43 was highly expressed in myotubes in the P-ETC/EHS
border zone. Scale bars ¼ 50 mm.
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been achieved by various methods,18,19 usually including
preplating steps during the initial phase of culturing crude
primary cell suspensions. This technique serves to
separate cell populations on the basis of their attachment
to plastic surfaces and is often used for the removal of
unwanted fibroblasts, but also for the enrichment of
specific multipotent progenitor cell populations.20,21 In
our case, SMBs were acquired from neonatal tissue for
reasons of cell culture compatibility and expansion
potential,22 and culture conditions were optimized to gener-
ate high numbers of functionally competent SMBs for the
subsequent fabrication of ETCs.
By applying directional mechanical strain on the tissue
constructs, the embedded SMBs were oriented in a longitu-
dinal fashion and condensation of the hydrogel led to a com-
pact and uniform distribution of cells. Furthermore, the
expression of gap junction proteins Cx43, Cx40, and N-cad-
herin was maintained during maturation of SMBs to myo-
tubes. This effect of mechanical signal transduction has
been described for the expression of genes involved in var-
ious mechanistic pathways,23 including the expression of
connexins,24,25 and is considered to be linked to integrins
and cadherins,26,27 whereas the exact mechanism is still
not fully understood. We showed that electrophysiologic
integration to cardiac tissue is only possible when SMB-
based ETCs are subjected to tensile strain, demonstrating
the necessity for mechanical preconditioning. This charac-
teristic of skeletal muscle–generated progenitor cells has
been described28 but never as a prerequisite for electrical
integration.
Nevertheless, SMBs have been one of the first cell popu-
lations that have been applied in clinical trials for cardiac
cell therapy,29 but they showed poor reproducible therapeu-
tic efficacy in the most recent clinical trials.2,30 The
induction of ventricular arrhythmias after SMB
transplantation has been a recurring and intensely debated
issue. A direct association of immature phenotypes of cell
transplants and decreased conduction velocity,31 as well1182 The Journal of Thoracic and Cardiovascular Suras improper alignment of gap junction and adherens pro-
teins, was demonstrated in vitro and in animal models.32
It is now generally accepted that resolving the challenges
regarding electrophysiologic integration remains a major
challenge in advancing the clinical utility of cell-based car-
diac therapies.33
The idea to modify gene expression from SMBs by pre-
conditioning is well established in these approaches.4 For
example, the transplantation of genetically modified
SMBs overexpressing Cx43 has been shown to prevent
postinfarction arrhythmia.11 This study demonstrated the
potential of tissue engineering and preconditioning of
SMBs to build gap junctions and to establish electrical cou-
pling with cardiac cells; however, genetic manipulation
limits the potential use of these cells in a clinical setting.
Vital EHSs34,35 co-cultured with ETCs allowed us to di-
rectly assess the quality of electrical integration using quan-
titative electrophysiologic parameters. We have shown that
SMBs within the ETCs couple electrophysiologically to the
EHSs after 6 days of co-culture. However, this coupling was
less robust when compared with electrophysiologic connec-
tions between cells in the native heart tissue.
Corresponding to our previous findings,14 which showed
that ETC grafts could augment the cardiac conduction sys-
tem in a rat model of atrioventricular conduction block, the
current study confirms the expression of Cx43 within the
transplanted ETC.
As a structural basis for electrical integration, expression
of Cx43 at the EHS–ETC interface was shown for the me-
chanically P-ETCs as opposed to the control NP-ETCs,
confirming the notion of Cx43 being essential for cardiac
electrophysiologic coupling.
Study Limitations
Calcium transient imaging experiments were not per-
formed because they were beyond the primary scope of
the present study. However, we recognized that the detailed
characterization of the calcium transients of the different
tissues may help identify the origin of potential ectopicgery c November 2012
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voltage- or calcium-sensitive dyes to further assess the con-
nectivity of the tissues using optical mapping as described
previously.14
Furthermore, the investigation of the contractile proper-
ties of SMBs embedded in the ETCs and their ability to cou-
ple mechanically to the host myocardium are of significant
importance. In vitro determination of developed force as fa-
tigue testing would provide further insight. In addition to
the in vivo electrical integration of the tissue constructs
that we confirmed previously,14 the functional in vivo inte-
gration of the tissue constructs needs to be investigated and
will be the subject of future projects.
CONCLUSIONS
We demonstrated electrophysiologic coupling of skeletal
myoblast–derived cells with cardiomyocytes in the context
of engineered tissues. This is a decisive step forward toward
the future application of autologous and functionally
competent cells as therapeutic agents for cardiac cell
therapy.
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Dr Y. Joseph Woo (Philadelphia, Pa). Dr Choi, I congratulate
you and your colleagues on an outstanding body of work. Your
work is very innovative. The mechanical preconditioning, your
in vitro transplant model of heart slices, sophisticateddiovascular Surgery c Volume 144, Number 5 1183
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Selectrophysiologic studies, proper biologic controls, and loss of
function and restoration of function controls all should be com-
mended. I have 2 quick questions.
Have you looked at any complementary studies of gap junction
function and electrophysiologic coupling, such as direct imaging
of calcium transients?
Dr Choi. We did not do that. We performed a dye transfer
experiment by immersing one end into calcium AM, the dye was
transferred, and the dye transfer could be stopped by additional ad-
ministration of 1-heptanol.
DrWoo.Would you comment on any ongoing in vivo studies or
speculate on your work transitioning into an in vivo model? Would1184 The Journal of Thoracic and Cardiovascular Surmultiple factors, such as the varied vectors of natural cardiac con-
tractility, potentially decondition your preconditioned myotubules
andmight your engineered construct serve as a focus for a reentrant
tachycardia?
Dr Choi. We also performed transplantation in vivo in mice,
and by small animal magnetic resonance imaging in these mice,
we observed that the size of the scar decreased and the contractility
of the left ventricle increased.
In regard to the other question, we are starting a clinical trial.
We are trying to translate everything to meet the Good
Manufacturing Practice guidelines, and we are just waiting for
approval.gery c November 2012
FIGURE E1. Masson’s trichrome staining of the co-culture samples at the junction of (A) killed engineered tissue construct (K-ETC)/EHS and (B)
nonpreconditioned engineered tissue construct (NP-ETC)/EHS shows poor grafting, whereas (C) preconditioned engineered tissue construct (P-ETC)/
EHS shows close contact of adjacent tissues. D-F, Staining of ETCs shows a majority of dead (propidium iodide positive) cells for K-ETC (D), whereas
NP-ETC (E) and P-ETC (F) show mainly vital (calcein AM positive) cells. G, Macroscopic fluorescence picture of Vybrant Dil (red) labeled EHS co-
culture with calcein AM (green) labeled EHS to show poor attachment of adjacent tissues. H, Spontaneous AP of EHS. I, APs of P-ETC/EHS co-
culture during 2-heptanol treatment and after washout. Scale bars ¼ 50 mm.
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